Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide.

M. Kawalec, G. Hoser, T. Skórski, J. Kawiak

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Cyclophosphamide/mafosfamide-resistant L 1210 cell line [L 1210(Cy)R] was established from a sensitive parental line. The L 1210(Cy)R line was resistant to cyclophosphamide at the dose of 100 mg/kg. Cells of L 1210(Cy)R line were more immunogenic for semisyngeneic CD2F1, mice as compared with parental line. They grew slower in immunocompetent mice compared to immunosuppressed mice. It has been shown that L 1210(Cy)R cells treated with mafosfamide at high concentration not only retained immunogenicity but were even more immunogenic than parental L 1210 cells. In conclusion, it was possible to produce immunogenic, nondividing leukemia cells even when cells were resistant to the cytostatic used for cell modification.

Original languageEnglish
Pages (from-to)63-66
Number of pages4
JournalFolia Histochemica et Cytobiologica
Volume31
Issue number2
StatePublished - 1993

Fingerprint

Dive into the research topics of 'Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide.'. Together they form a unique fingerprint.

Cite this